Related references
Note: Only part of the references are listed.Anti-tumor activity of olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in cultured endometrial carcinoma cells
Aki Miyasaka et al.
BMC CANCER (2014)
Poly (ADP-ribose) polymerase inhibitor LT-626: Sensitivity correlates with MRE11 mutations and synergizes with platinums and irinotecan in colorectal cancer cells
Lisa A. McPherson et al.
CANCER LETTERS (2014)
Microsatellite instability induced mutations in DNA repair genes CtIP and MRE11 confer hypersensitivity to poly (ADP-ribose) polymerase inhibitors in myeloid malignancies
Terry J. Gaymes et al.
HAEMATOLOGICA (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Sequencing of Candidate Chromosome Instability Genes in Endometrial Cancers Cancers Reveals Somatic Mutations in ESCO1, CHTF18, and MRE11A
Jessica C. Price et al.
PLOS ONE (2013)
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma
Siming Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib
Anneleen Daemen et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Mre11-Dependent Degradation of Stalled DNA Replication Forks Is Prevented by BRCA2 and PARP1
Songmin Ying et al.
CANCER RESEARCH (2012)
Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment
Lenka Oplustilova et al.
CELL CYCLE (2012)
PTEN Deletion in Prostate Cancer Cells Does Not Associate with Loss of RAD51 Function: Implications for Radiotherapy and Chemotherapy
Michael Fraser et al.
CLINICAL CANCER RESEARCH (2012)
p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans
Peter J. Wild et al.
EMBO MOLECULAR MEDICINE (2012)
Role of MRE11 in Cell Proliferation, Tumor Invasion, and DNA Repair in Breast Cancer
Shyng-Shiou F. Yuan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
MRE11 Deficiency Increases Sensitivity to Poly(ADP-ribose) Polymerase Inhibition in Microsatellite Unstable Colorectal Cancers
Eduardo Vilar et al.
CANCER RESEARCH (2011)
Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations
Konstantin J. Dedes et al.
CELL CYCLE (2011)
Searching for synthetic lethality in cancer
Rachel Brough et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)
Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer
Martin D. Forster et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Emerging therapeutic targets in endometrial cancer
Konstantin J. Dedes et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
The MRE11 complex: starting from the ends
Travis H. Stracker et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer
Ananya Choudhury et al.
CANCER RESEARCH (2010)
Double strand break repair components are frequent targets of microsatellite instability in endometrial cancer
Cristina Bilbao et al.
EUROPEAN JOURNAL OF CANCER (2010)
The MRN complex in double-strand break repair and telomere maintenance
Brandon J. Lamarche et al.
FEBS LETTERS (2010)
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
Andrew Tutt et al.
LANCET (2010)
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
M. William Audeh et al.
LANCET (2010)
PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP Inhibitors
Konstantin J. Dedes et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Systemic therapy for recurrent endometrial cancer: a review of North American trials
Thanh H. Dellinger et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Molecular and pathologic aspects of endometrial carcinogenesis
Jonathan L. Hecht et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
ECC-1 cells: A well-differentiated steroid-responsive endometrial cell line with characteristics of luminal epithelium
Bilan Mo et al.
BIOLOGY OF REPRODUCTION (2006)
Recruitment of ATR to sites of ionising radiation-induced DNA damage requires ATM and components of the MRN protein complex
KE Adams et al.
ONCOGENE (2006)
Mutations of an intronic repeat induce impaired MRE11 expression in primary human cancer with microsatellite instability
G Giannini et al.
ONCOGENE (2004)
BLM and the FANC proteins collaborate in a common pathway in response to stalled replication forks
P Pichierri et al.
EMBO JOURNAL (2004)
MRE11 expression is impaired in gastric cancer with microsatellite instability
L Ottini et al.
CARCINOGENESIS (2004)
EGR2 induces apoptosis in various cancer cell lines by direct transactivation of BNIP3L and BAK
M Unoki et al.
ONCOGENE (2003)
Human MRE11 is inactivated in mismatch repair-deficient cancers
G Giannini et al.
EMBO REPORTS (2002)
Share Paper
